Befloxatone
![]() | |
| Names | |
|---|---|
| IUPAC name
(R)-5-(methoxymethyl)-3-(4-((R)-4,4,4-trifluoro-3-hydroxybutoxy)phenyl)-oxazolidin-2-one | |
| Identifiers | |
| 134564-82-2 | |
| 3D model (Jmol) | Interactive image |
| ChEMBL | ChEMBL416578 |
| ChemSpider | 54811 |
| 6637 | |
| KEGG | D02563 |
| PubChem | 60824 |
| UNII | 4H75PAD8M3 |
| |
| |
| Properties | |
| C15H18F3NO5 | |
| Molar mass | 349.30233 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| | |
| Infobox references | |
Befloxatone (MD-370,503) is a reversible inhibitor of monoamine oxidase A.[1][2]
References
- ↑ Emilien, G (March 1999). "Befloxatone (Synthelabo)". IDrugs. 2 (3): 247–253. PMID 16160936.
- ↑ Warot, Dominique; Berlin, Ivan; Patat, Alain; Durrieu, Geneviève; Zieleniuk, Isabelle; Puech, Alain J (October 1996). "Effects of Befloxatone, a Reversible Selective Monoamine Oxidase-A Inhibitor, on Psychomotor Function and Memory in Healthy Subjects". The Journal of Clinical Pharmacology. 1552-4604. Blackwell Publishing Ltd. 36 (10): 942–950. doi:10.1002/j.1552-4604.1996.tb04762.x. PMID 8930782.
This article is issued from Wikipedia - version of the 9/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
